# Cyclerion Therapeutics, Inc. (CYCN)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/CYCN/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -4.93M | $ -2.61M | $ 0 | $ 5.09M |
| 2025 | $ 2.12M | $ -3.61M | $ -3.39M | $ 0 | $ 9.09M |
| 2024 | $ 2.10M | $ -3.21M | $ -4.55M | $ 0 | $ 8.85M |
| 2023 | $ 0 | $ -5.69M | $ -22.97M | $ 0 | $ 11.29M |
| 2022 | $ 1.14M | $ -49.24M | $ -45.37M | $ 0 | $ 10.45M |
| 2021 | $ 4.69M | $ -61.39M | $ -43.41M | N/A | $ 48.25M |
| 2020 | $ 2.92M | $ -99.11M | $ -94.29M | $ 45.74M | $ 59.49M |
| 2019 | $ 5.82M | $ -158.77M | $ -140.82M | $ 73.92M | $ 97.73M |
| 2018 | $ 0 | $ -152.21M | $ -133.31M | $ 0 | $ -10.45M |
| 2017 | $ 0 | $ -71.19M | N/A | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.36 |
| Current Ratio | 0.82 |

## Other views

- [Metrics](https://sponda.capital/en/CYCN.md)
- [Charts](https://sponda.capital/en/CYCN/charts.md)
- [Compare](https://sponda.capital/en/CYCN/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.